skip to primary navigation skip to content


Winton Centre for Risk and Evidence Communication


Although the Winton Centre's priorities are in the applications of knowledge in the real world, we do also publish our academic work in order to share our knowledge, data and experiences with others. Because we publish in order to maximise access to our work, all our publications are Gold Open Access (we do not publish in journals that do not offer this option), and we pre-register our hypotheses and methods wherever suitable.

All our code is published Open Source on GitHub.

Winton Centre Publications

Recchia, G., Chiappi, A., Chandratillake, G., Raymond, L., & Freeman, A. L. (2019). Creating genetic reports that are understood by nonspecialists: a case study. Genetics in Medicine, 1-9.

Freeman, A.L.J. (2019) How to communicate evidence to patients. Drug and Therapeutics Bulletin, 57(8): 119-124.

Anne Marthe van der Bles, Sander van der Linden, Alexandra L. J. Freeman, James Mitchell, Ana B. Galvao, Lisa Zaval, & David J. Spiegelhalter (2019). Communicating uncertainty about facts, numbers and science. Royal Society Open Science, 6(5)

Freeman, A.L.J. & Spiegelhalter, D.J. (2018). Communicating health risks in science publications: time for everyone to take responsibility. BMC Medicine, 16: 207.

Brick, C., & Spiegelhalter, D. J. (2018). Winners and Losers: Communicating the Potential Impacts of Policies: Commentary on Zeller. Nicotine & Tobacco Research.

Brick, C., Freeman, A. L., Wooding, S., Skylark, W. J., Marteau, T. M., & Spiegelhalter, D. J. (2018). Winners and losers: communicating the potential impacts of policies. Palgrave Communications4(1), 1-13.

Spiegelhalter D. (2017) Risk and uncertainty communication Annual Review of Statistics and Its Application , 4: 31-60

Freeman, A., Marshall, M., Treadwell, J., Spiegelhalter, D. and Rafi, I., 2017. Communicating risk in primary care: what the Academy of Medical Sciences’ report means in practice. British Journal of General Practice, 67(661): 346-347.

Other publications by Prof Spiegelhalter

These are not all necessarily Gold Open Access

Elisabeth M. Stephens, David J. Spiegelhalter, Ken Mylne, and Mark Harrison (2019) The Met Office Weather Game: investigating how different methods for presenting probabilistic weather forecasts influence decision-making. Geosci. Commun., 2, 101-116, 2019

Spiegelhalter, D. (2018). Commentary on Piumatti et al. 2018. Journal of Public Health.

Rakow T., Blackshaw E., Pagel C., Spiegelhalter D. (2018) Comparing what to what, on what scale? The impact of item comparisons and reference points in communicating risk and uncertainty. J Behav. Dec. Making, 31: 547-561.

Spiegelhalter, D. (2017). Trust in numbers. Journal of the Royal Statistical Society: Series A (Statistics in Society)180(4), 948-965.

Spiegelhalter DJ. (2017) Discussion of "The ASA's p-value statement, one year on" by Robert Matthews Significance, 14: 38-41

Pagel C, Jesper E, Thomas J, Blackshaw E, Rakow T, Pearson M, Spiegelhalter D. (2017) Understanding Children's Heart Surgery Data: A Cross-Disciplinary Approach to Codevelop a Website. Ann Thorac Surg, 104: 342-352

Gage J and Spiegelhalter DJ (2016) Teaching Probability, Cambridge University Press; Cambridge (CUP page)

Spiegelhalter D (2016) How old are you, really? Communicating chronic risk through 'effective age' of your body and organs. BMC Med Inform Decis Mak263: 727-732, DOI: 10.1186/s12911-016-0342-z

Mamidanna R, Ni Z, Anderson O, Spiegelhalter SD, Bottle A, Aylin P, Faiz O, Hanna GB (2016) Surgeon Volume and Cancer Esophagectomy, Gastrectomy, and Pancreatectomy: A Population-based Study in England. Ann Surg263: 727-732, DOI: 10.1097/SLA.0000000000001490

Rhodes KM, Turner RM, White IR, Jackson D, Spiegelhalter DJ, Higgins JPT (2016) Implementing informative priors for heterogeneity in meta-analysis using meta-regression and pseudo data. Statistics in Medicine30DOI: 10.1002/sim.7090

Spiegelhalter DJ. (2016) David Spiegelhalter: Doesn't like Hunt's use of statistics British Medical Journal354(link)

Grieve R, Abrams K, Claxton K, Goldacre B, James N, Nicholl J, Parmar M, Parker C, Sekhon JS, Smeeth L, Spiegelhalter D. (2016) Cancer Drugs Fund requires further reform British Medical Journal354DOI: 10.1136/bmj.i5090